Literature DB >> 18377844

Non-small cell lung cancer.

David S Ettinger, Wallace Akerley, Gerold Bepler, Andrew Chang, Richard T Cheney, Lucian R Chirieac, Thomas A D'Amico, Todd L Demmy, Steven J Feigenberg, Robert A Figlin, Ramaswamy Govindan, Frederic W Grannis, Thierry Jahan, Mohammad Jahanzeb, Anne Kessinger, Ritsuko Komaki, Mark G Kris, Corey J Langer, Quynh-Thu Le, Renato Martins, Gregory A Otterson, Jyoti D Patel, Francisco Robert, David J Sugarbaker, Douglas E Wood.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18377844     DOI： 10.6004/jnccn.2008.0021

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  8 in total

1.  How to deal with complicate hilar or interlobar lymphadenopathy during video-assisted thoracoscopic surgery lobectomy.

Authors:  Zhenrong Zhang; Deruo Liu; Yongqing Guo; Tong Bao; Fei Xiao; Qianli Ma; Chaoyang Liang
Journal:  J Vis Surg       Date:  2016-01-21

2.  Quality of life of lung cancer patients receiving outpatient chemotherapy.

Authors:  Ayako Matsuda; Mika Kobayashi; Yumi Sakakibara; Meiyo Tamaoka; Masashi Furuiye; Naohiko Inase; Eisuke Matsushima
Journal:  Exp Ther Med       Date:  2011-01-05       Impact factor: 2.447

3.  The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.

Authors:  William Boland; Gwyn Bebb
Journal:  Biologics       Date:  2010-11-09

4.  Zoledronic acid treatment in advanced non-small cell lung cancer patients with bone metastases.

Authors:  Zhengbo Song; Yiping Zhang
Journal:  Med Oncol       Date:  2014-02-27       Impact factor: 3.064

Review 5.  Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer.

Authors:  Yelena Krupitskaya; Billy W Loo
Journal:  Curr Treat Options Oncol       Date:  2009-04-22

Review 6.  Management of small-cell lung cancer: incremental changes but hope for the future.

Authors:  Christine L Hann; Charles M Rudin
Journal:  Oncology (Williston Park)       Date:  2008-11-30       Impact factor: 2.990

7.  PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival.

Authors:  Wenfeng Fang; Shaodong Hong; Nan Chen; Xiaobo He; Jianhua Zhan; Tao Qin; Ting Zhou; Zhihuang Hu; Yuxiang Ma; Yuanyuan Zhao; Ying Tian; Yunpeng Yang; Cong Xue; Yanna Tang; Yan Huang; Hongyun Zhao; Li Zhang
Journal:  Oncotarget       Date:  2015-10-20

8.  Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options.

Authors:  Long Huang; Xiao-Liu Jiang; Hong-Bin Liang; Jian-Cheng Li; Li-Han Chin; Jian-Ping Wei; Rui-Ru Wang; Jing Cai; Qiang Xiong; Lien-Tu Wang; David S Cram; An-Wen Liu
Journal:  Mol Med       Date:  2020-09-17       Impact factor: 6.354
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.